| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Chief Financial Officer | Ordinary Shares | 134K | $1.64M | $12.23 | Nov 4, 2025 | Direct |
| NovoCure Ltd | Chief Financial Officer | Stock Options (Right to buy) | 81.5K | $1.48M | $18.19 | Mar 4, 2025 | Direct |
| NovoCure Ltd | Chief Financial Officer | Restricted Share Units | 60.3K | Jan 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | Nov 4, 2025 | 1 | -$86K | 4 | Nov 4, 2025 | Chief Financial Officer |
| NVCR | NovoCure Ltd | Jul 29, 2025 | 3 | $232K | 4 | Jul 30, 2025 | Chief Financial Officer |
| NVCR | NovoCure Ltd | Mar 4, 2025 | 2 | $2.48M | 4 | Mar 6, 2025 | Chief Financial Officer |
| NVCR | NovoCure Ltd | Jan 1, 2025 | 0 | $0 | 3 | Jan 6, 2025 | CFO |